We are live on ! Find out more
AVEO

AVEO Pharmaceuticals, Inc.
AVEO

Delisted

AVEO was delisted on the 19th of January, 2023.

Back to rankings

35 hedge funds and large institutions have $15.6M invested in AVEO Pharmaceuticals, Inc. in 2020 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 12 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% more call options, than puts

Call options by funds: $4.06M | Put options by funds: $3.54M

0% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 12

41% less capital invested

Capital invested by funds: $26.5M → $15.6M (-$11M)

43% less funds holding

Funds holding: 61 → 35 (-26)

77% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 30

Holders
35
Holders Change
-26
Holders Change %
-42.62%
% of All Funds
0.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
12
Reduced
12
Closed
30
Calls
$4.06M
Puts
$3.54M
Net Calls
+$516K
Net Calls Change
-$607K

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$557K
2
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$194K
3
GCP
GSA Capital Partners
United Kingdom
+$48K
4
WA
WealthTrust Axiom
Pennsylvania
+$39.7K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$32.3K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$212K
2
Bank of New York Mellon
Bank of New York Mellon
New York
-$61K
3
State Street
State Street
Massachusetts
-$50K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$48K
5
CAN
Cetera Advisor Networks
California
-$42K
Name Holding Trade Value Shares
Change 		Change in
Stake
EWM
26
Edge Wealth Management
New York
$4K – – –
Royal Bank of Canada
27
Royal Bank of Canada
Ontario, Canada
$3K – – –
UBS Group
28
UBS Group
Switzerland
$2K -$14K -2,818 -85%
Fidelity Investments
29
Fidelity Investments
Massachusetts
$2K +$1.24K +250 +125%
Osaic Holdings
30
Osaic Holdings
Arizona
$2K +$2.13K +430 New
Millennium Management
31
Millennium Management
New York
– -$212K -34,024 Closed
Bank of New York Mellon
32
Bank of New York Mellon
New York
– -$61K -9,812 Closed
State Street
33
State Street
Massachusetts
– -$50K -7,961 Closed
CAN
34
Cetera Advisor Networks
California
– -$42K -5,590 Closed
PCS
35
Personal CFO Solutions
New Jersey
– -$34K -5,390 Closed
EM
36
Excalibur Management
Massachusetts
– -$32K -5,100 Closed
Goldman Sachs
37
Goldman Sachs
New York
– -$28K -4,488 Closed
SIM
38
Spark Investment Management
New York
– -$23K -3,700 Closed
California Public Employees Retirement System
39
California Public Employees Retirement System
California
– -$21K -3,340 Closed
RJA
40
Raymond James & Associates
Florida
– -$21K -3,330 Closed
AFP
41
Ausdal Financial Partners
Iowa
– -$17K -3,300 Closed
D.E. Shaw & Co
42
D.E. Shaw & Co
New York
– -$20K -3,128 Closed
SXL
43
Summit X LLC
Missouri
– -$18K -2,930 Closed
Charles Schwab
44
Charles Schwab
California
– -$18K -2,863 Closed
CIBC Private Wealth Group
45
CIBC Private Wealth Group
Georgia
– -$17K -2,700 Closed
GC
46
Grimes & Company
Massachusetts
– -$14K -2,260 Closed
CC
47
Cannell & Co
New York
– -$12K -2,000 Closed
WS
48
Wedbush Securities
California
– -$12K -2,000 Closed
Citigroup
49
Citigroup
New York
– -$8.81K -1,775 -99%
ECM
50
ExodusPoint Capital Management
New York
– -$11K -1,770 Closed
1
2
3

AVEO Hedge Fund Activity: Q1 2020 in Review

35 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in AVEO Pharmaceuticals, Inc. (AVEO) for Q1 2020, worth a combined $15.6M — down 41% from $26.5M a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of AVEO and 7 opened new positions — a net loss of 23 holders — while 12 trimmed existing stakes and 12 added.

The largest buyer was Sabby Management, opening a new position worth an estimated $557K. The largest seller was Millennium Management, exiting entirely with an estimated $212K sold.

  • 35 institutional investors held AVEO Pharmaceuticals, Inc. (AVEO) as of Q1 2020, down from 61 in Q4 2019.
  • Funds reported $15.6M of AVEO Pharmaceuticals, Inc. stock for Q1 2020, down 41% quarter-over-quarter.
  • 7 funds opened new AVEO Pharmaceuticals, Inc. positions in Q1 2020 and 30 closed out, a net change of -23 holders.
  • The largest AVEO Pharmaceuticals, Inc. buyer in Q1 2020 was Sabby Management, an estimated $557K added.
  • The largest AVEO Pharmaceuticals, Inc. seller in Q1 2020 was Millennium Management, an estimated $212K sold.

Based on aggregated 13F filings for Q1 2020.